Holaira is committed to conducting rigorous clinical studies that help advance medical care for patients with obstructive lung diseases. Detailed information regarding all Holaira clinical studies can be found at www.clinicaltrials.gov.
Current Clinical Studies:
AIRFLOW Clinical Study (NCT02058459) – Enrollment Completed
||This is a multi-center, interventional clinical trial.
||The goal of the phased AIRFLOW clinical study will be:
AIRFLOW-1: to compare two energy doses and select the optimal energy prior to AIRFLOW-2 dose and confirm safety and feasibility (recruitment closed)
AIRFLOW-2: to compare outcomes between the optimal energy dose vs. a sham control.
||Moderate to severe COPD (chronic obstructive pulmonary disease)
||Austria, Belgium, France, Germany, Netherlands, United Kingdom.
Additional information and a list of participating clinical sites can be found at www.airflowtrial.com.